<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22">
 <label>22.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Johnson-Ajinwo</surname>
    <given-names>OR</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ullah</surname>
    <given-names>I</given-names>
   </name>, 
   <name name-style="western">
    <surname>Mbye</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Richardson</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Horrocks</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Li</surname>
    <given-names>WW</given-names>
   </name>
  </person-group>
  <year>2018</year>
  <article-title>The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents</article-title>. 
  <source>Bioorg Med Chem Lett</source>
  <volume>28</volume>:
  <fpage>1219</fpage>â€“
  <lpage>1222</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2018.02.051</pub-id>.
  <pub-id pub-id-type="pmid">29519737</pub-id>
 </mixed-citation>
</ref>
